Rockwell Medical Inc

NASDAQ RMTI

Data sourced from

and

Download Data

Rockwell Medical Inc Pre-Tax Margin for the quarter ending March 31, 2024: -8.24%

Rockwell Medical Inc Pre-Tax Margin is -8.24% for the quarter ending March 31, 2024, a -13.60% change year over year. Pre-tax margin represents the proportion of a company's earnings before taxes (EBT) to its revenue. It is calculated by dividing the EBT by the revenue. This ratio indicates the profitability of the company's operations before the impact of taxes. A higher pre-tax margin suggests that the company generates a larger proportion of revenue as pre-tax profit, indicating stronger operational performance and efficiency.

Rockwell Medical Inc Pre-Tax Margin for the quarter ending March 31, 2023 was -7.26%, a 86.68% change year over year.
Rockwell Medical Inc Pre-Tax Margin for the quarter ending March 31, 2022 was -54.48%, a -17.55% change year over year.
Rockwell Medical Inc Pre-Tax Margin for the quarter ending March 31, 2021 was -46.35%, a 6.79% change year over year.
Rockwell Medical Inc Pre-Tax Margin for the quarter ending March 31, 2020 was -49.72%, a 12.33% change year over year.

NASDAQ: RMTI

Rockwell Medical Inc

CEO	Dr. Mark Strobeck Ph.D.
IPO Date	Jan. 27, 1998
Location	United States
Headquarters	30142 South Wixom road, Wixom, MI, United States, 48393
Employees	237
Sector	Healthcare
Industry	Drug manufacturers - specialty & generic

Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Key trends